Clinical Trials Logo

Intestinal Diseases, Parasitic clinical trials

View clinical trials related to Intestinal Diseases, Parasitic.

Filter by:

NCT ID: NCT05856721 Not yet recruiting - Liver Cirrhosis Clinical Trials

Pattern of Intestinal Parasitic Infection Among Cirrhotic Patients in Sohag University Hospital

Start date: June 2023
Phase: N/A
Study type: Interventional

Chronic hepatic illness is one of the most serious health issues . Liver cirrhosis as the latest phase of chronic liver disease causes a disorder called cirrhosis-associated immune dysfunction syndrome (CAIDS) . Cirrhosis comes to be a systemic disease, with several organ disorders. At this phase, patients become highly vulnerable to various infections because of CAIDS, which comprises both innate and adaptive immunity). Patients with hepatic cirrhosis and ascites are more liable to other complications of liver disease, including hyponatremia, refractory ascites, or hepatorenal syndrome (HRS) . Liver cirrhotic patients are considered to be as immunosuppressed and are vulnerable to a different species of entero-parasites . Intestinal parasitic diseases have been reported in association with diabetes mellitus (DM) which is considered a predisposing factor to infection in cirrhotic patients . Immunosuppression among DM cases is due to increased blood glucose levels, which modifies several immune responses and this renders the body susceptible to various opportunistic infections comprising parasitic infections Intestinal parasites such as Blastocystis hominis, Cryptosporidium spp., Isospora belli, Cyclospora cayetanensis, and Microsporidia have appeared as significant opportunistic parasites that are responsible for severe illness in immunocompromised patients , subsequently, patients suffer from severe morbidity and high mortality).

NCT ID: NCT05850884 Recruiting - Clinical trials for Intestinal Parasites in Patients With Intestinal Cancer

Evaluation of Intestinal Parasites in Patients With Intestinal Cancer in Sohag, Egypt.

Start date: November 30, 2023
Phase:
Study type: Observational [Patient Registry]

This study aims to evaluate the intestinal parasitic infections in patients with intestinal cancer in comparison to non-cancer individuals

NCT ID: NCT05830370 Recruiting - Clinical trials for Irritable Bowel Syndrome

Prevalence of Intestinal Parasitic Infections in Patients With Irritable Bowel Syndrome

Start date: May 1, 2023
Phase:
Study type: Observational

Irritable bowel syndrome (IBS) is common medical disorder and represent a group of diseases of the gastrointestinal tract that is characterized by chronic abdominal pain , bloating , passage of mucus or straining with bowel movements, sense of incomplete evacuation after bowel movements or sense of urgency to move the bowels.Several parasites including Entamoeba. histolytica, Giardia spp., Blastocystis. hominis, and Trichinella spp. have been discussed as contributing factors to the development of IBS. B. hominis is one of the most common human intestinal protozoa in both developing and developed countries. some studies have reported a significant association between the parasitic infections, especially Blastocystis, and IBS.Cryptosporidium has been reported in IBS patients, with the onset of gastrointestinal symptoms after an acute episode of cryptosporidiosis despite recovery and parasite clearance.Numerous studies have been conducted to evaluate the association between the parasitic infections and IBS. Aim of the work: To detect prevalence of intestinal parasitic infections in irritable bowel syndrome patients in sohag.

NCT ID: NCT05360940 Recruiting - Clinical trials for Dyspepsia Abdominal Burning Pain Diarrhea Dysentery

Concomitant Infection of Intestinal Parasites and Helicobacter Pylori

Start date: September 2022
Phase:
Study type: Observational

Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in the world especially in developing countries. Helicobacter pylori is a gram-negative,helical-shaped,motile bacillus bacterium,which colonizes the gastric mucosa. H.pylori bacterium secretes urease,a special enzyme that converts urea to ammonia. Ammonia reduces the stomach's acidity .This risk factor allows pathogenic intestinal protozoa such as G.lamblia to take the opportunity to cross through the stomach's increased pH and cause disease.

NCT ID: NCT05360472 Not yet recruiting - Clinical trials for Intestinal Parasitic Infection

Evaluation of Feconomics for Diagnosis of Intestinal Parasitic Infections

Start date: July 1, 2022
Phase:
Study type: Observational

People of all ages are affected by intestinal parasitic infections(IPIs) ; however, children are the most commonly affected, which is linked to their poor hygienic practices, and weak immune status. In children, IPIs are associated with malabsorption, weight loss, anemia, poor growth rate, learning difficulties, mental retardation and intellectual problems . The difficulty of diagnosis is the main problem in the control of intestinal parasitic infections. The choice of a particular technique is usually influenced by affordability, simplicity, cost, sensitivity in addition to the level of technical skills involved. Microscopic examination remains the cornerstone of parasitological diagnosis which is time consuming and requires an experienced observer to identify the organism. Formalin-ether sedimentation technique is commonly used in laboratories owing to its ability to isolate a large variety of parasites. However, it's a labor intensive procedure and is usually associated with hazards of using the inflammable lipid solvents. The drawbacks of the previous techniques have encouraged the development of commercial products such as Feconomics which is a new ready to use kit for concentration of stool samples in parasitological diagnosis. The aim of the study is : evaluation of the efficacy of Feconomics technique in comparison to traditional techniques i.e., direct smear and formalin ethyl acetate sedimentation technique for the diagnosis of intestinal parasites in school children.

NCT ID: NCT03930901 Completed - Clinical trials for Knowledge, Attitudes, Practice

Impact of Health Education Learning Package Against Intestinal Parasitic Infections Among Orang Asli Children

Start date: April 18, 2017
Phase: N/A
Study type: Interventional

A health education learning package (HELP) has been improved and evaluated for its impact against intestinal parasitic infections among Orang Asli schoolchildren in West Malaysia. 13 schools were allocated into two groups (intervention and control groups) and the impact of HELP was evaluated after 3 and 6 months of baseline assessment and HELP intervention.

NCT ID: NCT03490435 Completed - Chronic Disease Clinical Trials

Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland

Start date: February 17, 2018
Phase:
Study type: Observational

The goal of the proposed study is to assess the prevalence of intestinal parasitic diseases in adults and children. These invasions are included to "dirty hand diseases" (per os invasions), therefore it applies mainly preschool children.

NCT ID: NCT03173001 Active, not recruiting - Colorectal Cancer Clinical Trials

Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

Colorectal cancer (CRC) has the third highest cancer incidence in the world. There is mounting evidence that the intestinal microbiota plays an important role in colorectal carcinogenesis. but there is no information on protozoa of intestinal microbiota except Blastocystis hominis, although data on this issue is scarce. In this study we are going to evaluate the prevalence of intestinal helminthes and protozoa in CRC patients and control group that includes random residents. Patients will be examined before, after surgery and chemotherapy. Parasites and protozoan infection intensity will be estimated by triple coproscopy.

NCT ID: NCT03079700 Completed - Ulcerative Colitis Clinical Trials

Immune Modulation From Trichuris Suis

Start date: August 1, 2012
Phase: N/A
Study type: Observational

Mucosal immunology during helminth infection

NCT ID: NCT02597556 Withdrawn - Diarrhea Clinical Trials

The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children

Start date: February 2016
Phase: Phase 4
Study type: Interventional

Cheap and effective drugs called 'anthelmintics' are routinely administered to children in developing countries to eliminate infections by parasitic helminths. However, the effects of anthelmintic treatment on other pathogens (e.g., bacteria, viruses, protozoa) remain unknown. The aim of this study is to investigate the impact of anthelmintic treatment on the incidence of viral- and bacterial-induced diarrhea in school children in southern Vietnam. Diarrheal disease remains a substantial cause of morbidity and mortality in children in Vietnam, and these children are typically co-infected with intestinal helminths. As helminths and diarrheal pathogens infect the same intestinal niche, anthelmintic treatments may alter host immune responses and the composition of the gut microbiota in ways that affect infection and disease risks caused by diarrheal pathogens. This study will recruit 350 helminth-infected and 350 helminth-uninfected children aged 6-15 years. Recruited children will be randomized to receive either anthelmintic or placebo treatment once every three months and will be monitored for incidences of diarrheal disease for 12 months. At the 12-month time point, all children will receive anthelmintic treatment. Blood and stool samples will be collected throughout the study and used for evaluation of anemia and host immune responses, and for classification of gut microbes and parasite detection, respectively. The interventional study proposed here will provide an important first test of whether anthelmintic treatments have any indirect effects on infections caused by diarrheal pathogens.